Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding

Antiviral Therapy

Volumn 15, Issue 6, 2010, Pages 913-916

  Nieuwkerk, Pythia T ^a   De Boer Van Der Kolk, I Marion ^a   Prins, Jan M ^a   Locadia, Mirjam ^a   Sprangers, Mirjam A G ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; SOCIAL DESIRABILITY; TREATMENT RESPONSE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRES; SELF REPORT; SOCIAL DESIRABILITY;

EID: 77957356438     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1644     Document Type: Article

References (11)

1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30.
2. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14:357-366.
3. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001; 134:968-977.
4. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 2006; 43 Suppl 1:S79-S87.
5. Wagner G, Miller LG. Is the influence of social desirability on patients' self-reported adherence overrated? J Acquir Immune Defic Syndr 2004; 35:203-204.
6. Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav 2007; 11:161-173.
7. Simoni JM, Frick PA, Lockhart D, Liebovitz D. Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patient Care STDS 2002; 16:431-439.
8. Altice FL, Mostashari F, Friedland GH. Trust and acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 28:47-58.
9. Tourangeau R, Yan T. Sensitive questions in surveys. Psychol Bull 2007; 133:859-883.
10. Van Sighem AI, van de Wiel MA, Ghani AC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. ATHENA Cohort Study Group. AIDS 2003; 17:2227-2236.
11. Hays RD, Hayashi T, Stewart AL. A five-item measure of socially desirable response set. Educ Psychol Meas 1989; 49:629-636.